Study in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium

NCT03682497 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
68
Enrollment
INDUSTRY
Sponsor class

Stopped Attendance at study sites carries risk of COVID-19 infection. Non-attendance at planned study site visits has unacceptable study related patient safety risk.

Conditions

Interventions

Sponsor

AstraZeneca